Ribbon and IBM Partner to deliver Unified Communications as a Service

 

Communication, collaboration and remote capabilities have always been an integral part of how companies relate with customers and shareholders – and the COVID-19 pandemic has thrust these business drivers even further into the spotlight.

To help businesses stay at the leading-edge in the application of these core tools and strategies, IBM and Ribbon Communications have partnered to create an innovative unified communications service ready to deliver powerful results.

Ribbon Director of Solutions Marketing, Greg Zweig, joined host Tyler Kern to outline that solution and provide insight about how it will shape the way businesses communicate and develop customer experiences not only during this uncertain period, but well into the “new normal” that is sure to follow.

“Ribbon and IBM have actually been working together for a number of years, and, as a result of this COVID-19 situation, we were lucky enough to come up with a way to be able to offer IBM customers no-charge, cloud-based unified communications licenses for our Smart Office Collaboration suite,” Zweig said.

Smart Office Collaborations is Ribbon’s suite of intuitive, powerful communication tools for delivering voice, video, instant messaging, and more across desktop and mobile devices, allowing users to gain a common experience across virtually any device and reduce the cost and complexity of traditional unified communications deployments.

This innovative unified communications as a service, or UCaaS, approach for IBM customers offers a key avenue for companies to remain engaged and productive during this unprecedented time, Zweig said.

“As many companies are struggling, and their employees are struggling, to figure out how to work more effectively from home, having some free licenses – and these are available through June 30 of this year – really helps bridge the gap between working in the office and working at home,” he said.

It’s a simple offering, but also a robust one. With this free license, companies will empower their employees to work from any device and connect quickly and efficiently anytime, anywhere, 100% virtually.

Combined with third-party integration, custom colors for branding, live-call switching, and IBM’s unique ability to serve any company, of any size, anywhere on the planet, it’s a truly unmatched offering.

Innovating in this space is nothing new for Ribbon – the company prides itself on helping customers “modernize their networks for improved competitive positioning and business outcomes in today’s smart, always-on and data hungry world.”

To learn more about the Ribbon-IBM offering visit rbbn.com/IBM-work@home.

For more B2B thought leadership and expertise, visit MarketScale’s industry publication pages.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More